Authors
Loading...
Preclinical study demonstrates superior tumor suppression with a dual-action nanocomposite in mice, highlighting a versatile nanoplatform for combined chemo-chemodynamic therapy.
Chatterjee et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: